SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing
SonoSite of Bothell, WA, this month received premarket clearance for its digital hand-held ultrasound unit. The company announced April 5 that the Food and Drug Administration had cleared the device and that SonoSite would begin its marketing efforts.
Last May, SonoSites prototype device received premarket clearance, which covered 11 clinical applications including obstetrical, gynecological, abdominal, and cardiovascular imaging (SCAN 5/13/98). The new clearance covers such updates to the prototype as increased signal processing ability, and adds transrectal imaging to the devices list of applications. SonoSites scanner will weigh less than 6 pounds and the firm expects to begin selling the units late this year.
The company moved quickly to establish distributor partnerships for the unit, announcing April 7 that it had signed an agreement with Esaote of Genoa, Italy. The agreement gives Esaote distribution rights for the new device in Germany, France, Italy, and the Netherlands.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.